Japanese Pharmaceuticals & Biotech Most Popular Stocks

AnGes

Market Cap: JP¥30.1b

Engages in the research and development of gene-based medical products.

Pharma Foods International

Market Cap: JP¥23.3b

Engages in the development and sale of functional food ingredients in Japan.

Astena Holdings

Market Cap: JP¥20.7b

Manufactures and sells medicine-related products in Japan.

Japan Tissue Engineering

Market Cap: JP¥20.1b

Engages in the regenerative medicine business in Japan.

Renascience

Market Cap: JP¥20.0b

Engages in the development and commercialization of pharmaceuticals and medical devices in Japan.

CanBas

Market Cap: JP¥19.9b

A clinical stage biopharmaceutical company, develops therapeutics for cancer patients.

StemRIM

Market Cap: JP¥18.3b

A biotechnology company, develops regeneration medicines for the treatment of intractable diseases.

Fuso Pharmaceutical IndustriesLtd

Market Cap: JP¥17.9b

Manufactures and sells pharmaceuticals and medical equipment in Japan.

ReproCELL

Market Cap: JP¥17.6b

Provides stem cell research and drug discovery services in Japan.

Oncolys BioPharma

Market Cap: JP¥16.6b

Engages in the research, development, manufacture, sale, import, and export of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the rest of Asia, and the United States.

CellSeed

Market Cap: JP¥14.8b

Develops cell sheet regenerative medicines.

RaQualia Pharma

Market Cap: JP¥13.7b

Engages in the research and development of pharmaceutical compounds worldwide.

Stella Pharma

Market Cap: JP¥12.0b

Engages in the research, development, manufacturing, and distribution of pharmaceuticals.

Kidswell Bio

Market Cap: JP¥11.9b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

CellSource

Market Cap: JP¥11.0b

Engages in the regenerative medicine-related businesses in Japan.

Wakamoto PharmaceuticalLtd

Market Cap: JP¥10.0b

Manufactures and sells ethical and non-prescription drugs in Japan.

Solasia Pharma K.K

Market Cap: JP¥9.7b

Engages in the development and marketing of oncology drugs in Japan and other Asian countries.

NANO MRNALtd

Market Cap: JP¥9.2b

Researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan.

MEDINET

Market Cap: JP¥9.0b

Operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan.

Chordia Therapeutics

Market Cap: JP¥8.9b

A biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan.

Tsubota Laboratory

Market Cap: JP¥8.8b

Engages in the development and sale of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, presbyopia, and neurological disorders.

Chiome Bioscience

Market Cap: JP¥8.6b

Engages in the research and development of drug discovery technology platforms worldwide.

MedRx

Market Cap: JP¥8.1b

A pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan.

Kohjin Bio

Market Cap: JP¥7.9b

Manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics.

Linical

Market Cap: JP¥7.7b

Provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide.

K PharmaInc

Market Cap: JP¥7.7b

Engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan.

Noile-Immune Biotech

Market Cap: JP¥7.4b

Researches and develops CAR-T cells for cancer immunotherapies.

OncoTherapy Science

Market Cap: JP¥7.0b

Engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan.

TMS

Market Cap: JP¥6.8b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.

SymBio Pharmaceuticals

Market Cap: JP¥6.4b

Engages in the research and development, manufacturing, and sales of pharmaceuticals and related operations to treat cancer, hematology, and viral infectious diseases in Japan and internationally.

WDB coco

Market Cap: JP¥6.4b

Provides contract services to pharmaceutical companies in Japan.

Modalis Therapeutics

Market Cap: JP¥6.1b

Engages in the research and development of therapeutics to treat patients with serious genetic disorders.

BrightPath Biotherapeutics

Market Cap: JP¥6.0b

Engages in the development of cancer immunotherapy drugs in Japan.

NPTLtd

Market Cap: JP¥5.8b

Engages in clinical development of new drugs and treatments for personalized medicines.

Nippon Chemiphar

Market Cap: JP¥5.8b

Engages in the manufacture, sale, import, and export of ethical pharmaceuticals and diagnostic agents in Japan and internationally.

PRISM BioLabLTD

Market Cap: JP¥5.8b

A biotechnology company, discovers and develops small molecule inhibitors of protein-protein interaction targets utilizing proprietary PepMetics technology for treating patients suffering from cancer, autoimmune, fibrosis, and other diseases.